Drug Pricing Congress

Stakeholder Initiatives on Value Frameworks, Price Assessments, Cost-Effectiveness, Innovation and Sustainability

The drum beat around escalating drug pricing has intensified, and various models, frameworks and assessment methodologies are rapidly materializing. The implications for all stakeholders within the healthcare system are paramount, and the opportunity to steer the course is now.

This one-day event will convene stakeholders stretching across the healthcare system, including government regulators, manufacturers, health plans, PBMs, medical associations, patient groups and quality measures organizations. Hear expert perspectives on the issues driving escalating drug pricing, the development of therapy value frameworks, private sector initiatives and emerging models for sustaining innovative, cost-effective and value-driven healthcare.

Who Should Attend:

You will benefit from attending this event if you have responsibilities or involvement in the following areas:

• Health Policy
• Pricing
• Contracting
• Reimbursement
• Pharmacy
• Benefit Management
• Value Assessment
• Medicare
• Health Economics/HEOR
• Patient Access
• Managed Markets
• Compliance